Literature DB >> 29129476

Pyroptosis and its relationship to atherosclerosis.

Yuan-Jun Xu1, Lei Zheng1, Yan-Wei Hu2, Qian Wang3.   

Abstract

Pyroptosis is a pro-inflammatory form of regulated cell death and is dependent on the enzymatic activity of inflammatory proteases that belong to the family of cysteine-dependent aspartate-specific proteases (caspases). Pyroptosis is morphologically, mechanistically, and pathophysiologically distinct from other forms of cell death, including apoptosis and necrosis. Pyroptosis is characterized by rapid plasma membrane rupture, with the consequent release of intracellular contents and pro-inflammatory mediators, including interleukin (IL)-1β, IL-18, and the alarmin HMGB-1.Recent studies have shown that pyroptosis may be involved in atherosclerosis and play an important role in atherosclerotic lesion instability. Here, we review the progress made in understanding the morphological, molecular, and pathophysiological mechanisms of pyroptosis and its potential role in atherosclerosis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Caspase-1; Inflammation; Pyroptosis

Mesh:

Year:  2017        PMID: 29129476     DOI: 10.1016/j.cca.2017.11.005

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  68 in total

1.  Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis.

Authors:  Sha-Sha Xing; Jin Yang; Wen-Jing Li; Jian Li; Lin Chen; Yu-Ting Yang; Xia Lei; Jun Li; Kai Wang; Xun Liu
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

2.  LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia-reperfusion injury by regulating by the miR-17-5p/CCND1 axis.

Authors:  Hui Kang; Hui Yu; Ling Zeng; Hao Ma; Ge Cao
Journal:  Hypertens Res       Date:  2022-03-09       Impact factor: 3.872

3.  Potential of nobiletin against Alzheimer's disease through inhibiting neuroinflammation.

Authors:  Wen Chai; Ji Zhang; Zhengbing Xiang; Honglian Zhang; Zhujun Mei; Hongbing Nie; Renxu Xu; Ping Zhang
Journal:  Metab Brain Dis       Date:  2022-03-10       Impact factor: 3.584

4.  NF-κB/ABCA1 pathway aggravates ox-LDL-induced cell pyroptosis by activation of NLRP3 inflammasomes in THP-1-derived macrophages.

Authors:  Jiashan Li; Jiaru Liu; Ying Yu; Yuee Liu; Xiuru Guan
Journal:  Mol Biol Rep       Date:  2022-05-17       Impact factor: 2.742

Review 5.  Pyroptosis in stroke-new insights into disease mechanisms and therapeutic strategies.

Authors:  Xue Gou; Dan Xu; Fengyang Li; Kai Hou; Weirong Fang; Yunman Li
Journal:  J Physiol Biochem       Date:  2021-05-04       Impact factor: 4.158

Review 6.  Different types of cell death in vascular diseases.

Authors:  Shirin Saberianpour; Abbas Karimi; Mohammad Hadi Saeed Modaghegh; Mahdi Ahmadi
Journal:  Mol Biol Rep       Date:  2021-05-19       Impact factor: 2.316

7.  Carbon Monoxide-Releasing Molecule-3 Alleviates Kupffer Cell Pyroptosis Induced by Hemorrhagic Shock and Resuscitation via sGC-cGMP Signal Pathway.

Authors:  Xu-Peng Wang; Wei-Chao Zheng; Yang Bai; Yan Li; Yue Xin; Jing-Zhou Wang; Yu-Lin Chang; Li-Min Zhang
Journal:  Inflammation       Date:  2021-02-11       Impact factor: 4.092

8.  Melatonin attenuates smoking-induced atherosclerosis by activating the Nrf2 pathway via NLRP3 inflammasomes in endothelial cells.

Authors:  Zhewei Zhao; Xuebin Wang; Rui Zhang; Baitao Ma; Shuai Niu; Xiao Di; Leng Ni; Changwei Liu
Journal:  Aging (Albany NY)       Date:  2021-04-04       Impact factor: 5.682

Review 9.  Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.

Authors:  Qingxue Xu; Bo Zhao; Yingze Ye; Yina Li; Yonggang Zhang; Xiaoxing Xiong; Lijuan Gu
Journal:  J Neuroinflammation       Date:  2021-05-31       Impact factor: 8.322

10.  Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury.

Authors:  Wenwen Cui; Shen Xin; Lingjuan Zhu; Mingye Wang; Yuanyuan Hao; Yuqian Zhao; Yang Li; Yunlong Hou
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.